CIP
IDXX icon

Convergence Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Convergence Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-558
Closed -$301K – 262
2024
Q1 		$301K Buy
+558
New +$305K 0.12% 199
2023
Q4 		– Sell
-496
Closed -$217K – 202
2023
Q3 		$217K Buy
+496
New +$247K 0.13% 143
2023
Q2 		– Sell
-694
Closed -$347K – 179
2023
Q1 		$347K Buy
+694
New +$332K 0.2% 109
2022
Q1 		– Sell
-462
Closed -$304K – 229
2021
Q4 		$304K Sell
462
-130
-22% -$81.6K 0.15% 139
2021
Q3 		$368K Sell
592
-109
-16% -$73.2K 0.2% 117
2021
Q2 		$443K Sell
701
-129
-16% -$71.2K 0.19% 114
2021
Q1 		$406K Buy
830
+121
+17% +$60.6K 0.19% 115
2020
Q4 		$354K Sell
709
-2,205
-76% -$987K 0.18% 119
2020
Q3 		$1.15M Buy
+2,914
New +$1.08M 0.4% 88
2019
Q2 		– Sell
-2,710
Closed -$606K – 346
2019
Q1 		$606K Buy
+2,710
New +$559K 0.13% 187
2018
Q2 		– Sell
-50
Closed -$10K – 586
2018
Q1 		$10K Buy
+50
New +$9.23K ﹤0.01% 699
2017
Q1 		– Sell
-19,095
Closed -$2.24M – 355
2016
Q4 		$2.24M Buy
+19,095
New +$2.18M 0.31% 122

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Convergence Investment Partners's IDXX Position: Q2 2024 in Review

Convergence Investment Partners sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 558 shares — an estimated $301K sold.

Convergence Investment Partners first reported a position in IDXX in Q4 2016 and held it in 12 quarters. The position peaked at $2.24M in Q4 2016. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Convergence Investment Partners reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Convergence Investment Partners sold 558 Idexx Laboratories shares in Q2 2024, an estimated $301K.
  • Convergence Investment Partners first reported a position in Idexx Laboratories in Q4 2016 and held it in 12 quarters.
  • Convergence Investment Partners's Idexx Laboratories position peaked at $2.24M in Q4 2016.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Convergence Investment Partners's 13F filing for Q2 2024, filed 1 Aug 2024.